A new study by University of Bath scientists has highlighted two new potential families of drug molecules that could open the ...

PROVIDENCE, R.I. (AP) — A federal judge has ruled that the recent mass layoffs at the U.S. Health and Human Services were ...

Jeremy Gregson was sitting in his Northwest Indiana home two years ago when he got the call that his blood work from earlier ...

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

HIV drug resistance is caused by mutations in the genetic structure of HIV that may affect the ability of medicines to block the replication of the virus.

Knowing the structure of the molecule you’re targeting helps you find or make a drug that will fit.” Knowledge of HIV Pol’s structure sheds new light on how HIV reproduces itself.

"Structure informs function, and the insights we gained from visualizing the molecular architecture of Pol give us a new understanding of the mechanism by which HIV replicates," said co-senior ...

The researchers were them able to use electron tomography and subtomogram averaging to analyze the interactions between the HIV-1 capsid and two molecules, Cyclophilin A (CypA), and cofactor IP6 ...